366 related articles for article (PubMed ID: 15204022)
1. Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid.
Raman C; McAllister SD; Rizvi G; Patel SG; Moore DH; Abood ME
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Mar; 5(1):33-9. PubMed ID: 15204022
[TBL] [Abstract][Full Text] [Related]
2. Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival.
Weydt P; Hong S; Witting A; Möller T; Stella N; Kliot M
Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Sep; 6(3):182-4. PubMed ID: 16183560
[TBL] [Abstract][Full Text] [Related]
3. The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset.
Shoemaker JL; Seely KA; Reed RL; Crow JP; Prather PL
J Neurochem; 2007 Apr; 101(1):87-98. PubMed ID: 17241118
[TBL] [Abstract][Full Text] [Related]
4. Benefit of valproic acid in suppressing disease progression of ALS model mice.
Sugai F; Yamamoto Y; Miyaguchi K; Zhou Z; Sumi H; Hamasaki T; Goto M; Sakoda S
Eur J Neurosci; 2004 Dec; 20(11):3179-83. PubMed ID: 15579172
[TBL] [Abstract][Full Text] [Related]
5. AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis.
Kim K; Moore DH; Makriyannis A; Abood ME
Eur J Pharmacol; 2006 Aug; 542(1-3):100-5. PubMed ID: 16781706
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis.
Kiaei M; Kipiani K; Chen J; Calingasan NY; Beal MF
Exp Neurol; 2005 Feb; 191(2):331-6. PubMed ID: 15649489
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effect of activity-dependent neurotrophic factor against toxicity from familial amyotrophic lateral sclerosis-linked mutant SOD1 in vitro and in vivo.
Chiba T; Hashimoto Y; Tajima H; Yamada M; Kato R; Niikura T; Terashita K; Schulman H; Aiso S; Kita Y; Matsuoka M; Nishimoto I
J Neurosci Res; 2004 Nov; 78(4):542-52. PubMed ID: 15478191
[TBL] [Abstract][Full Text] [Related]
8. Fas small interfering RNA reduces motoneuron death in amyotrophic lateral sclerosis mice.
Locatelli F; Corti S; Papadimitriou D; Fortunato F; Del Bo R; Donadoni C; Nizzardo M; Nardini M; Salani S; Ghezzi S; Strazzer S; Bresolin N; Comi GP
Ann Neurol; 2007 Jul; 62(1):81-92. PubMed ID: 17503505
[TBL] [Abstract][Full Text] [Related]
9. Pyruvate slows disease progression in a G93A SOD1 mutant transgenic mouse model.
Park JH; Hong YH; Kim HJ; Kim SM; Kim MJ; Park KS; Sung JJ; Lee KW
Neurosci Lett; 2007 Feb; 413(3):265-9. PubMed ID: 17174029
[TBL] [Abstract][Full Text] [Related]
10. Opposing effects of low and high-dose clozapine on survival of transgenic amyotrophic lateral sclerosis mice.
Turner BJ; Rembach A; Spark R; Lopes EC; Cheema SS
J Neurosci Res; 2003 Nov; 74(4):605-13. PubMed ID: 14598305
[TBL] [Abstract][Full Text] [Related]
11. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
[TBL] [Abstract][Full Text] [Related]
12. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
Cervetto C; Frattaroli D; Maura G; Marcoli M
Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
[TBL] [Abstract][Full Text] [Related]
13. Manganese porphyrin given at symptom onset markedly extends survival of ALS mice.
Crow JP; Calingasan NY; Chen J; Hill JL; Beal MF
Ann Neurol; 2005 Aug; 58(2):258-65. PubMed ID: 16049935
[TBL] [Abstract][Full Text] [Related]
14. Ivermectin inhibits AMPA receptor-mediated excitotoxicity in cultured motor neurons and extends the life span of a transgenic mouse model of amyotrophic lateral sclerosis.
Andries M; Van Damme P; Robberecht W; Van Den Bosch L
Neurobiol Dis; 2007 Jan; 25(1):8-16. PubMed ID: 17045808
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic benefit of intrathecal injection of insulin-like growth factor-1 in a mouse model of Amyotrophic Lateral Sclerosis.
Nagano I; Ilieva H; Shiote M; Murakami T; Yokoyama M; Shoji M; Abe K
J Neurol Sci; 2005 Aug; 235(1-2):61-8. PubMed ID: 15990113
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis.
Bordet T; Buisson B; Michaud M; Drouot C; Galéa P; Delaage P; Akentieva NP; Evers AS; Covey DF; Ostuni MA; Lacapère JJ; Massaad C; Schumacher M; Steidl EM; Maux D; Delaage M; Henderson CE; Pruss RM
J Pharmacol Exp Ther; 2007 Aug; 322(2):709-20. PubMed ID: 17496168
[TBL] [Abstract][Full Text] [Related]
17. DL-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis.
Feng X; Peng Y; Liu M; Cui L
Neuropharmacology; 2012 Feb; 62(2):1004-10. PubMed ID: 22056419
[TBL] [Abstract][Full Text] [Related]
18. A dopamine receptor antagonist L-745,870 suppresses microglia activation in spinal cord and mitigates the progression in ALS model mice.
Tanaka K; Okada Y; Kanno T; Otomo A; Yanagisawa Y; Shouguchi-Miyata J; Suga E; Kohiki E; Onoe K; Osuga H; Aoki M; Hadano S; Itoyama Y; Ikeda JE
Exp Neurol; 2008 Jun; 211(2):378-86. PubMed ID: 18423451
[TBL] [Abstract][Full Text] [Related]
19. Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model.
Wang R; Zhang D
Eur J Neurosci; 2005 Nov; 22(9):2376-80. PubMed ID: 16262676
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human erythropoietin suppresses symptom onset and progression of G93A-SOD1 mouse model of ALS by preventing motor neuron death and inflammation.
Koh SH; Kim Y; Kim HY; Cho GW; Kim KS; Kim SH
Eur J Neurosci; 2007 Apr; 25(7):1923-30. PubMed ID: 17439481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
